The DOI matches its Crossref record; 68 of the 69 references it cites were found in a registry or an index.
Tumor-associated fibroblasts predominantly come from local and not circulating precursors
Open accessAbstract
Significance: Fibroblasts constitute an important element of tumors and have received considerable attention in recent years due to their tumor-promoting and immunosuppressive properties. As a consequence, tumor-associated fibroblasts (TAFs) are considered an attractive target for cancer therapies. However, their origin remains controversial, with some evidence pointing at a local origin, whereas many publications suggest a significant contribution of progenitors from bone marrow. We found that TAFs derive almost exclusively from local sources. Therefore, therapeutic strategies to target fibroblasts must exploit local recruitment and the unique transcriptional and response patterns of fibroblasts from different sites.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The gradual nature of the transitions observed has given rise to the view that the majority of stromal fibroblasts initially originate from local fibroblasts that experience some form of tissue dysfunction31,32.”
From A framework for advancing our understanding of cancer-associated fibroblasts (2020) · cites this paper as [32]
Citations
Cites
Fiji: an open-source platform for biological-image analysis
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2019 · Cited by 66,890
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Stöckl, S., Göttl, C., Grifka, J. K., & Grässel, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350089 · Cited by 4,670
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
A perivascular origin for mesenchymal stem cells in multiple human organs
Crisan, M., Yap, S., Casteilla, L., Chen, C.-W., Corselli, M., Park, T. S., Andriolo, G., Sun, B., Zheng, B., Zhang, L., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.07.003 · Cited by 3,991 · cited 1×
“MSCs are radioresistant (43, 44), reside in multiple organs in perivascular locations (45), and have migratory capability (45).”
BackgroundOlive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Mesenchymal stem cells reside in virtually all post-natal organs and tissues
Meirelles, L. D. S., Chagastelles, P. C., & Nardi, N. B. (2006) · Journal of Cell Science · doi:10.1242/jcs.02932 · Cited by 2,472
Provenzano, P. P., Cuevas, C., Chang, A. E., Goel, V. K., Von Hoff, D. D., & Hingorani, S. R. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.01.007 · Cited by 2,195
Klinge, U., Park, J.-K., & Klosterhalfen, B. (2013) · Pathobiology · doi:10.1159/000348446 · Cited by 1,791
A Dominant Mutation That Predisposes to Multiple Intestinal Neoplasia in the Mouse
Moser, A. R., Pitot, H. C., & Dove, W. F. (1990) · Science · doi:10.1126/science.2296722 · Cited by 1,591
Flagged first, then by citations
1 of the 69 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- A Maximov, Culture of blood leukocytes. From lymphocytes and monocytes to connective tissue. Arch Exp Zellforsch 5, 169–268 (1928).
- DH Cormack Essential Histology (Lippincott Williams & Wilkins, 2nd Ed, Philadelphia, 2001).
Cited by
Sorted by citations
Items 101–200 of 238
Aghakhani, S., Zerrouk, N., & Niarakis, A. (2020) · Cancers · doi:10.3390/cancers13010035 · Cited by 32
Interplay between Prostate Cancer and Adipose Microenvironment: A Complex and Flexible Scenario
Cancel, M., Pouillot, W., Mahéo, K., Fontaine, A., Crottès, D., & Fromont, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810762 · Cited by 31
Overcoming cancer treatment resistance: Unraveling the role of cancer-associated fibroblasts
Wang, X., Zhou, Y., Wang, Y., Yang, J., Li, Z., Liu, F. L., Wang, A., Gao, Z., Wu, C. H., & Yin, H. (2025) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2025.03.002 · Cited by 32
Self-citationXue, X., Wang, X., Pang, M., Yu, L., Qian, J., Li, X., Tian, M., Lu, C. Y., Xiao, C., & Liu, Y. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02452-1 · Cited by 29
Park, M. N., Kim, M., Lee, S., Kang, S., Ahn, C., Tallei, T. E., Kim, W., & Kim, B. (2025) · Antioxidants · doi:10.3390/antiox14050501 · Cited by 35
Cancer-Associated Fibroblasts in Esophageal Cancer
Dunbar, K. J., Wong, K., & Rustgi, A. K. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.01.008 · Cited by 31
Zhu, J., Zhang, K., Chen, Y., Ge, X., Wu, J., Xu, P., & Yao, J. J. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05307-3 · Cited by 30
Fibroblast Subsets in Intestinal Homeostasis, Carcinogenesis, Tumor Progression, and Metastasis
Dang, H., Harryvan, T. J., & Hawinkels, L. J. A. C. (2021) · Cancers · doi:10.3390/cancers13020183 · Cited by 26
Musa, M., & Ali, A. (2020) · Future Oncology · doi:10.2217/fon-2020-0384 · Cited by 26
Fan, C., Zhu, W., Chen, Y., Zhu, W., & Ding, J. (2025) · MedComm · doi:10.1002/mco2.70415 · Cited by 30
Zeng, J., Peng, Y., Wang, D., Ayesha, K., & Chen, S. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1123065 · Cited by 31
Why does understanding the biology of fibroblasts in immunity really matter?
Wong, Z. Y., Nee, E., Coles, M. C., & Buckley, C. D. (2023) · PLoS Biology · doi:10.1371/journal.pbio.3001954 · Cited by 25
Feng, T.-Y., Azar, F. N., Rosean, C. B., McGinty, M. T., Putelo, A. M., Kolli, S. H., Marino, N., German, R., Podicheti, R., Dreger, S. A., et al. (2022) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-1120 · Cited by 22
Modeling the tumor immune microenvironment for drug discovery using 3D culture
Lee, J. Y., & Chaudhuri, O. (2021) · APL Bioengineering · doi:10.1063/5.0030693 · Cited by 22
Barrera, L. N., Ridley, P., Bermejo‐Rodríguez, C., Costello, E., & Pérez-Mancera, P. A. (2022) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-022-00899-0 · Cited by 22
Lafin, J. T., Sarsour, E. H., Kalen, A. L., Wagner, B. A., Buettner, G. R., & Goswami, P. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20010225 · Cited by 20
Chen, N., Ma, P., Qu, L.-W., Wu, F., Hao, J., Wang, R., Lu, Y., Yang, W. C., Erben, U., & Qin, Z. (2017) · The Journal of Pathology · doi:10.1002/path.4907 · Cited by 20
Wang, M., Zhao, Y., Xu, K., Liu, C., Zhong, H., Wu, Y., Zhang, K., & Wei, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1617968 · Cited by 23
Molecular phenotypes and spatial archetypes: A new framework for cancer-associated fibroblasts
Liu, Y., Chen, X., Dai, Y., Jia, Y., Kieffer, Y., Xie, L., Zhou, Z., Tyler, L. A., Kim, A. C., Biffi, G., et al. (2026) · Cancer Cell · doi:10.1016/j.ccell.2026.06.001 · Cited by 19
Arina, A., Karrison, T., Galka, E., Schreiber, K., Weichselbaum, R. R., & Schreiber, H. W. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0293 · Cited by 18
Self-citationInteractions between radiotherapy resistance mechanisms and the tumor microenvironment
Li, D., Wang, J., Li, X., Wang, Z., Yu, Q., Koh, S., Wu, R., Ye, L., Guo, Y., Okoli, U. A., et al. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104705 · Cited by 20
Effect of cancer-associated fibroblasts on radiosensitivity of cancer cells
Ji, X., Zhu, X., & Lu, X. (2017) · Future Oncology · doi:10.2217/fon-2017-0054 · Cited by 18
Razmkhah, M., Abtahi, S., & Ghaderi, A. A. (2018) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x13666180816114809 · Cited by 18
Heidary, Z., Ghaisari, J., Moein, S., & Javanmard, S. H. (2020) · PLoS ONE · doi:10.1371/journal.pone.0232965 · Cited by 18
Life of Pi: Exploring functions of Pi16+ fibroblasts
McCartney, E. E., Chung, Y., & Buechler, M. B. (2024) · F1000Research · doi:10.12688/f1000research.143511.1 · Cited by 17
Ueki, A., Komura, M., Koshino, A., Wang, C., Nagao, K., Homochi, M., Tsukada, Y., Ebi, M., Ogasawara, N., Tsuzuki, T., et al. (2023) · Cancers · doi:10.3390/cancers15030606 · Cited by 18
Axemaker, H., Plesselova, S., Calar, K., Jorgensen, M. M., Wollman, J. W., & de la Puente, P. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2024.119801 · Cited by 22
Tan, J., Yu, J.-H., Hou, D., Xie, Y., Lai, D., Zheng, F., Yang, B., Zeng, J.-T., Chen, Y., Shen, L., et al. (2025) · Advanced Science · doi:10.1002/advs.202514008 · Cited by 18
Current Pathology Model of Pancreatic Cancer
Szymoński, K., Milian-Ciesielska, K., Lipiec, E. W., & Adamek, D. (2022) · Cancers · doi:10.3390/cancers14092321 · Cited by 15
Extracellular Vesicles: Biological Packages That Modulate Tumor Cell Invasion
Schmidtmann, M., & D’Souza‐Schorey, C. (2023) · Cancers · doi:10.3390/cancers15235617 · Cited by 17
Lu, X., Liang Cheng, C., Yang, C., Huang, J., & Chen, X. (2024) · The Innovation Medicine · doi:10.59717/j.xinn-med.2024.100094 · Cited by 17
Microenvironmental modulation of the developing tumour: an immune‐stromal dialogue
Jones, J. O., Moody, W. M., & Shields, J. D. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12773 · Cited by 16
Fu, X., Zhang, Y., Luo, Q., Ju, Y., & Song, G. (2023) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2023.0229 · Cited by 14
Götze, J., Nitschke, C., Uzunoglu, F. G., Pantel, K., Sinn, M., & Wikman, H. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.918795 · Cited by 15
Zhao, Y., Li, Y., Wang, P., Zhu, M., Wang, J., Xie, B., Tang, C., Ma, Y., Wang, S., Jin, S., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1474564 · Cited by 14
Zhang, J., Qi, J., Wei, H., Lei, Y., Yu, H., Liu, N., Zhao, L., & Wang, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.667645 · Cited by 14
Zawawi, S. S. A., & Musa, M. (2022) · Biology · doi:10.3390/biology11071014 · Cited by 14
Chen, M. J., Sheu, M., Cheng, T.-L., Roffler, S. R., Lin, S., Chen, Y.-J., Cheng, Y., Cheng, J., Chang, H.-Y., Wu, T.-Y., et al. (2021) · Biomaterials Science · doi:10.1039/d1bm01218e · Cited by 14
Zhou, M., Liu, H., Hui, J., Chen, Q., Zhao, Y., Wang, H., Liu, W. ‐., Bian, Y., Ji, S., Wang, B., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-25-0663 · Cited by 13
Komura, M., Wang, C., Ito, S., Kato, S., Ueki, A., Ebi, M., Ogasawara, N., Tsuzuki, T., Kasai, K., Kasugai, K., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052537 · Cited by 16
Peritumoral CD90+CD73+ cells possess immunosuppressive features in human non-small cell lung cancer
Wang, L., Yang, H., Dorn, P., Berezowska, S., Blank, F., Wotzkow, C., Marti, T. M., Peng, R., Harrer, N. E., Sommergruber, W., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103664 · Cited by 13
Dhungel, N., & Dragoi, A. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1379971 · Cited by 11
Chung, H. C., Cho, E. J., Lee, H., Kim, W., Oh, J., Kim, S., Lee, D., & Sung, C. O. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.487 · Cited by 12
Ramos, C., Walterskirchen, N., Knöbl, V., Zotter, C., Müller, C., Gerakopoulos, V., Rauch, A. E., Falk, L., Sachet, M., D’Angelo, E., et al. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217686 · Cited by 12
The Role of Organoids in Advancing Colorectal Cancer Research: Insights and Future Directions
Heydari, Z., Balaya, R. D. A., Sarkar, G., & Boardman, L. (2025) · Cancers · doi:10.3390/cancers17132129 · Cited by 12
Ribatti, D. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1481609 · Cited by 10
Ma, Q., Kang, R., Xu, R., Guan, Y., Chang, S., & Li, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1614815 · Cited by 11
Kou, Z., Liu, C., Zhang, W., Sun, C., Liu, L., & Zhang, Q. (2024) · International Journal of Oncology · doi:10.3892/ijo.2024.5642 · Cited by 11
Extracellular Vesicles in Reprogramming of the Ewing Sarcoma Tumor Microenvironment
Pachva, M. C., Lai, H., Jia, A.-L., Rouleau, M., & Sorensen, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.726205 · Cited by 11
Design of nano-delivery systems for pancreatic cancer immunotherapy
Fu, S., Gao, C., Yu, Q., Gong, R., Yang, Z., Zang, X., Shan, S., Mombrú, D., Romero, M., Mombrú, Á. W., et al. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.218098 · Cited by 11
Cao, Y. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1092667 · Cited by 10
FAP-Targeted Fluorescent Imaging Agents to Study Cancer-Associated Fibroblasts In Vivo
Deutsch, R. J., Schleyer, K. A., Das, R., Carrothers, J. E., Köhler, R. H., Vinegoni, C., & Weissleder, R. (2024) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.4c00426 · Cited by 9
The HOX code of human adult fibroblasts reflects their ectomesenchymal or mesodermal origin
Pfeiferová, L., Španko, M., Šáchová, J., Hradilová, M., Pienta, K. J., Valach, J., Machoň, V., Výmolová, B., Šedo, A., Bušek, P., et al. (2025) · Histochemistry and Cell Biology · doi:10.1007/s00418-025-02362-9 · Cited by 9
Aluksanasuwan, S., Somsuan, K., Ngoenkam, J., Chiangjong, W., Rongjumnong, A., Morchang, A., Chutipongtanate, S., & Pongcharoen, S. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2024.119736 · Cited by 10
Yang, C., Shu, J., Li, Y., Zhao, N., Liu, X., Tian, X., Sun, Z., Tabish, M. S., Hong, Y., Chen, K., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1469918 · Cited by 12
Cancer-Associated Fibroblasts: Major Co-Conspirators in Tumor Development
Singh, S., Singh, A. P., & Mitra, R. (2024) · Cancers · doi:10.3390/cancers16010211 · Cited by 8
McAndrews, K. M., Mahadevan, K. K., & Kalluri, R. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041411 · Cited by 8
Li, J., Huang, Y. Y., Fu, L., Shi, M., Hu, G., Du, F., Wang, Z., Xiao, Y., Zhang, Y., & Li, Y. (2025) · International Journal of Oncology · doi:10.3892/ijo.2025.5774 · Cited by 9
Yu, J., Wang, L. S., Liu, Z., & Liu, J. (2026) · Transport Phenomena · doi:10.1515/tp-2026-0023 · Cited by 7
Liu, R., Su, L., Gao, S., Liu, W., & Wang, H. (2026) · Advanced Science · doi:10.1002/advs.202510043 · Cited by 9
Fibroblast subtypes in pancreatic cancer and pancreatitis: from mechanisms to therapeutic strategies
Huang, H., Lu, W., Zhang, X., Pan, J., Cao, F., & Li, W. (2023) · Cellular Oncology · doi:10.1007/s13402-023-00874-x · Cited by 7
[Research Status of Tumor-associated Fibroblasts Regulating Immune Cells].
Mu, G., Zhang, W., Huang, J., Chen, Z., & Wang, J. (2022) · PubMed · doi:10.3779/j.issn.1009-3419.2022.101.04 · Cited by 6
Ito, S., Koshino, A., Wang, C., Otani, T., Komura, M., Ueki, A., Kato, S., Takahashi, H., Ebi, M., Ogasawara, N., et al. (2024) · The Journal of Pathology Clinical Research · doi:10.1002/2056-4538.12386 · Cited by 6
Shi, R., Zhang, N., Li, H., Hu, Z., Zhong, C., Du, W., & Yang, X. (2025) · Discover Oncology · doi:10.1007/s12672-025-01825-8 · Cited by 6
Chikamatsu, K., Takahashi, H., Ida, S., Tada, H., Uchida, M., Motegi, M., & Tomidokoro, Y. (2025) · Head & Neck · doi:10.1002/hed.28239 · Cited by 6
Transcriptional plasticity of fibroblasts in heart disease
Micheletti, R., & Alexanian, M. (2022) · Biochemical Society Transactions · doi:10.1042/bst20210864 · Cited by 7
Wang, Y., Xu, M., Yao, Y., Li, Y., Zhang, S., Fu, Y., & Wang, X. (2024) · Oncology Letters · doi:10.3892/ol.2024.14300 · Cited by 5
Self-citationHsu, C., Ahmed, A. T., Rab, S. O., Uthirapathy, S., Ballal, S., Kalia, R., Arya, R., Nathiya, D., Kariem, M., & KADHIM, A. J. (2025) · Experimental Cell Research · doi:10.1016/j.yexcr.2025.114424 · Cited by 6
Fang, Y., Tan, C., Zheng, Z., Yang, J., Tang, J., Guo, R., Silli, E. K., Chen, Z., Chen, J., Ge, R., et al. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116849 · Cited by 6
Self-citationChang, J., Lo, Z. H. Y., Alenizi, S., & Kovačević, Ž. (2023) · Cancers · doi:10.3390/cancers15102779 · Cited by 5
Nishikiori, N., Takada, K., Sato, T., Miyamoto, S., Watanabe, M., Hirakawa, Y., Sekiguchi, S., Furuhashi, M., Yorozu, A., Takano, K., et al. (2023) · Cells · doi:10.3390/cells12172160 · Cited by 5
Nikolaev, V. V., Kistenev, Y. V., Kröger, M., Zuhayri, H., & Darvin, M. E. (2023) · Journal of Biophotonics · doi:10.1002/jbio.202300223 · Cited by 5
Wang, M., Jiang, M., Xie, A., Zhang, N., & Xu, Y. (2024) · Human Molecular Genetics · doi:10.1093/hmg/ddae042 · Cited by 5
Li, J., Ren, X., Cao, L. L., Min, K., Wang, M., Lin, S., Lei, L., Tan, Z., Cheng, X., Li, X., et al. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02052-y · Cited by 4
EV-mediated asymmetrical crosstalk between CAFs and cancer cells in the tumor microenvironment
Santi, A., Moccia, A., Caselli, A., & Cirri, P. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189380 · Cited by 4
Mirza, S., Penny, C. B., Jain, N. K., & Rawal, R. (2023) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2023.100095 · Cited by 4
Søland, T. M., Lipka, A., Ruus, A., Molværsmyr, A.-K., Galtung, H. K., & Haug, T. M. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1456346 · Cited by 4
Exosomal microRNAs in cancer metastasis: A bridge between tumor micro and macroenvironment
Saadh, M. J., Khalifehsoltani, A., Hussein, A. H. A., Allela, O. Q. B., Sameer, H. N., Rizaev, J. A., Hameed, H. G., Idan, A. H., & Alsaikhan, F. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155666 · Cited by 7
Fibroblasts: Dangerous travel companions
Schreiber, H. W. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20181850 · Cited by 4
Self-citationRijal, G. (2021) · Bioengineering · doi:10.3390/bioengineering8110163 · Cited by 4
Bassi, G., Saqawa, M., Apolloni, L., Díaz‐Prado, S., Ollivier, E., Levergeois, R., Sandri, M., Campodoni, E., Cochonneau, D., Panseri, S., et al. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118956 · Cited by 3
NGF-mediated tumor–stroma crosstalk promotes prostate cancer aggressiveness
Donato, M. D., Giovannelli, P., Sio, M. D., Migliaccio, A., & Castoria, G. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07915-7 · Cited by 3
Intratumoral Fibrosis: Emerging Concepts and Therapeutic Opportunities
Cremasco, V., & Chang, J. J. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781788015783-00259 · Cited by 1
Radiation‐induced effects on TGF‐β and PDGF receptor signaling in cancer‐associated fibroblasts
Yang, N., Hellevik, T., Berzaghi, R., & Martínez-Zubiaurre, I. (2024) · Cancer Reports · doi:10.1002/cnr2.2018 · Cited by 2
Delgado, A. P., Nemajerová, A., Nelson, B. J., Rao, M., Li, J., Marchenko, N. D., Preall, J. B., Moll, U. M., Egeblad, M., & Powers, S. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.05.490693 · Cited by 3
Axemaker, H., Plesselova, S., Calar, K., Jorgensen, M. M., Wollman, J. W., & de la Puente, P. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.29.560158 · Cited by 3
Faa, G., Ziranu, P., Pretta, A., Cau, F., Castagnola, M., Spanu, D., Saba, G., D’Agata, A. P., Tiwari, E., Suri, J. S., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118145 · Cited by 2
Cancer-associated fibroblasts: The "Achilles' Heel" in thyroid tumor progression and therapy
Li, X., Han, H., Li, S., Yang, K., Yang, Z., Ma, L., & Zhao, Y. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.112213 · Cited by 3
Serum‐Inert Tandem‐Locked Fluorescent Probe for Specific Imaging of Intratumoral Complement System
Hu, Y., Wu, J., & Pu, K. (2026) · Advanced Materials · doi:10.1002/adma.72937 · Cited by 2
Zhou, Y., Yu, J., Sui, Q., Liao, L., Lv, R.-X., Liu, Y., He, S., Li, Y.-Q., Xu, Z.-H., Jia, Z., et al. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218683 · Cited by 2
Cau, F., Gerosa, C., Ziranu, P., Pretta, A., Piras, M., Fraschini, M., Eyken, P. V., Nasa, G. L., Castagnola, M., Coghe, F., et al. (2023) · Annals of Research in Oncology · doi:10.48286/aro.2023.76 · Cited by 2
Chen, R., Dai, J., Wang, B., Peng, G., Xun, Y., & Li, Y. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70320 · Cited by 2
Inhibition of ACVR1 in Cancer-Associated Fibroblasts Suppresses Colorectal Cancer Cell Growth
Kato, S., Miyoshi, N., Fujino, S., Horie, M., Yachida, S., Takeda, M., Sekido, Y., Hata, T., Hamabe, A., Ogino, T., et al. (2025) · Annals of Surgical Oncology · doi:10.1245/s10434-025-17765-0 · Cited by 1
The critical role of homing in TIL therapy success: From biology to clinical application
Mohammadi, Y., Khorramdelazad, H., Soleimanifar, N., Badalzadeh, M., Nicknam, M. H., & Kardar, G. A. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104930 · Cited by 1
The tumor-associated fibroblasts regulate urothelial carcinoma progression
Xiao, Y., Yang, J., Sun, M., Li, Y., Liu, Q., Leng, J., Yang, M., Wang, J., Li, H. H., Yang, C., et al. (2025) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjaf032 · Cited by 2
Targetable axes of tumor-associated macrophages: An MSF framework for precision immunotherapy
Lu, Z., Xu, M., Tang, J., Wang, X., Li, X., & Li, Q. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189458 · Cited by 1
Saputra, E. C., Vellarikkal, S. K., Li, L., Sun, H., Nguyen, K. D. P., Montano, A., Natarajan, S., Piccioni, F., Tamburino, A. M., Yu, X., et al. (2025) · Molecular Oncology · doi:10.1002/1878-0261.70153 · Cited by 1
Mapping the Tissue‐of‐Origins of Mesenchymal Stromal Cells in Injury Repair
Tang, X. T., Liu, Y. L., Du, Y. A., Wang, S., & Zhou, B. O. (2025) · Advanced Science · doi:10.1002/advs.202509533 · Cited by 1
Exploring the inherent susceptibility of cancer-associated fibroblasts to oncolytic virus infection
Dam, N., Ioannidis, G., Hawinkels, L. J. A. C., & Kemp, V. (2026) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2026.2617274 · Cited by 1
Metadata
- Authors
- Arina, A., Idel, C., Hyjek, E. M., Alegre, M.-L., Wang, Y., Bindokas, V. P., Weichselbaum, R. R., & Schreiber, H.
- Affiliations
- University of Chicago (US)
- Corresponding author
- Arina, Ainhoa
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2016-06-17
- Volume
- 113
- Issue
- 27
- Pages
- 7551-7556
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC4941507
- OpenAlex
- W2442704894
- Cited by
- 238
- References
- 69
- Citations by year
- 2026: 20 · 2025: 38 · 2024: 35 · 2023: 37 · 2022: 26 · 2021: 29 · 2020: 21 · 2019: 12 · 2018: 12 · 2017: 7 · 2016: 1
- FWCI
- 5.75
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- HHS | National Institutes of Health (P01-CA97296, R01-CA22677, R01-CA37516)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- cancer-associated fibroblasts, tumor stroma, fibroblast origin, type I collagen, parabiosis, bone marrow chimeras, skin grafting, tumor microenvironment, collagen deposition
- MeSH terms
- Cancer-Associated Fibroblasts, Actins, Animals, Mice, Inbred C57BL, Neoplasms, Experimental, Mice, Knockout, Collagen Type I, Cell Line, Tumor, Green Fluorescent Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review